WASHINGTON (AP) — The Supreme Court says companies cannot patent human genes, a decision that could profoundly affect the medical and biotechnology industries.In a unanimous decision, the court struck down patents held by Myriad Genetics Inc. on two genes linked to increased risk of breast and ovarian cancer.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=87533